ARS Pharmaceuticals Inc —— 季度财务数据 (NASDAQ:SPRY) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 42 M-40.74 M-39.59 M-47.05 M-43.48 M -170.87 M 投资活动产生的现金 -101.76 M29.06 M48.57 M-44.98 M24.11 M 56.77 M 融资活动产生的现金 70.92 M725 K2.7 M100.05 M1.13 M 104.6 M 自由现金流 41.7 M-40.83 M-39.64 M-47.24 M-43.48 M -171.21 M

新闻

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

Leerink上调ARS Pharmaceuticals目标价,看好销售扩张

Leerink raises ARS Pharmaceuticals stock price target on sales expansion

ARS Pharmaceuticals第四季度业绩超预期,股价上涨

Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises

ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript

ARS PharmaceuticalsQ1每股收益及营收超出预期

ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

Canadian Natural to Report Q4 Earnings: What's in the Offing?

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Raymond James重申ARS Pharmaceuticals股票强力买入评级